Edition:
United States

People: Amgen Inc (AMGN.O)

AMGN.O on Nasdaq

165.67USD
22 Jul 2016
Change (% chg)

$1.48 (+0.90%)
Prev Close
$164.19
Open
$164.78
Day's High
$166.33
Day's Low
$164.00
Volume
2,500,362
Avg. Vol
2,933,806
52-wk High
$181.81
52-wk Low
$130.09

Bradway, Robert 

Mr. Robert A. Bradway is the Chairman of the Board, President, Chief Executive Officer of Amgen Inc. Robert A. Bradway has served as our director since October 2011 and Chairman of the Board since January 1, 2013. Mr. Bradway has been our President since May 2010 and Chief Executive Officer since May 2012. From May 2010 to May 2012, Mr. Bradway served as our Chief Operating Officer. Mr. Bradway joined Amgen in 2006 as Vice President, Operations Strategy and served as Executive Vice President and Chief Financial Officer from April 2007 to May 2010. Prior to joining Amgen, he was a Managing Director at Morgan Stanley in London where, beginning in 2001, he had responsibility for the firm’s banking department and corporate finance activities in Europe. Mr. Bradway has been a director of Norfolk Southern Corporation, a transportation company, since July 2011, serving on its Audit and Governance and Nominating Committees. He has served on the board of trustees of the University of Southern California since April 2014 and on the advisory board of the Leonard D. Schaeffer Center for Health Policy and Economics at that university since 2012. Mr. Bradway holds a bachelor’s degree in biology from Amherst College and a master’s degree in business administration from Harvard Business School.

Basic Compensation

Total Annual Compensation, USD 1,505,770
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 14,591,900
Fiscal Year Total, USD 16,097,700

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 84,000 9,279,540.00
Name Fiscal Year Total

Robert Bradway

16,097,700

David Meline

6,592,620

Madhavan Balachandran

4,986,140

Sean Harper

5,607,820

Anthony Hooper

6,414,730

Brian McNamee

--
As Of  30 Dec 2015